Evidence map›Paper›PMID 31950878›Full record

ArticleStem cells and development2020

Safety and Efficacy of Human Adipose-Derived Stromal/Stem Cell Therapy in an Immunocompetent Murine Pressure Ulcer Model.

Joanna Bukowska, Andrea Alarcon Uquillas, Xiying Wu, Trivia Frazier, Katarzyna Walendzik, Mikaela Vanek, Dina Gaupp, Bruce A Bunnell, Paul Kosnik, Babak Mehrara and 3 more

Open access · greenAbstract read
In one paragraph

Article in Stem cells and development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Joanna BukowskaInstitute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.
Andrea Alarcon UquillasLaCell LLC, New Orleans, Louisiana.
Xiying WuLaCell LLC, New Orleans, Louisiana.
Trivia FrazierLaCell LLC, New Orleans, Louisiana.
Katarzyna WalendzikInstitute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.
Mikaela VanekDepartment of Biological Sciences, Loyola University New Orleans, New Orleans, Louisiana.
Dina GauppCenter for Stem Cell Research and Regenerative Medicine, Tulane University, New Orleans, Louisiana.
Bruce A BunnellCenter for Stem Cell Research and Regenerative Medicine, Tulane University, New Orleans, Louisiana.
Paul KosnikTissue Genesis LLC, Houston, Texas.
Babak MehraraMemorial Sloan Kettering Cancer Center, New York, New York.
Adam J KatzDepartment of Plastic and Reconstructive Surgery, Wake Forest University, Winston Salem, North Carolina.
Barbara Gawronska-KozakInstitute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.
Jeffrey M GimbleLaCell LLC, New Orleans, Louisiana.
Institute of Animal Reproduction and Food Research · PLTulane University · USXavier University of Louisiana · USLaCell (United States) · USLoyola University New Orleans · USMemorial Sloan Kettering Cancer Center · USTissue Genesis (United States) · USWake Forest University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Pressure injuries/ulcers are frequent complications in elderly, paraplegic, and quadriplegic patients, which account for considerable cost to the international health care economy and remain refractory to current treatment options. Autologous or allogeneic adult stromal/stem cells represent an alternative therapeutic approach. The current study extends prior findings by exploring the safety and efficacy of human adipose-derived stromal/stem cell (ASC) therapy in an established immunocompetent murine skin pressure ulcer model where dermal fibroblast cells (DFCs) served as a control. Human adipose tissue was processed using a closed system device designed for point-of-care use in the operating room and on file with the Food and Drug Administration. Cell characterization was performed using colony-forming unit-fibroblast, differentiation, and immunophenotypic assays in vitro. Wound healing was assessed over a 20-day period based on photomicrographs, histology, and immunohistochemistry. The isolated human ASCs displayed significantly greater colony formation relative to DFCs while both populations exhibited comparable immunophenotype and differentiation potential. Both fresh and cryopreserved human ASCs significantly accelerated and enhanced wound healing in young (2 month) mice of both sexes relative to DFC controls based on tissue architecture and CD68

Indexed as

Adipose TissueAdolescentAnimalsCell- and Tissue-Based TherapyCell DifferentiationCells, CulturedCryopreservationDisease Models, AnimalFemaleFibroblastsHumansMaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMiceMice, Inbred C57BLadipose-derived stromal/stem cells (ASCs)dermal fibroblast cells (DFC)pressure ulcer (PU)stromal vascular fraction (SVF) cells

Identifiers

PMID31950878
PMCPMC7153639
OpenAlexW2999685325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.